IndustryThe Babraham Institute aims to maximise the impact of its research through knowledge exchange and commercialisation, and our scientists work with other organisations to translate that research into action for social and economic benefit. Commercialisation is achieved in collaboration with the Institute’s wholly-owned trading arm, Babraham Institute Enterprise Limited.
Babraham Institute Enterprise is situated in the Babraham Research Campus. The Campus, which is considered to be the UK’s leading campus in supporting early-stage bioscience enterprise, is managed and developed Babraham Bioscience Technologies Ltd (BBT).
The Campus' bioincubator concept offers bespoke, state-of-the-art research and development facilities, scientific support services and/or bioventures at any stage in the business development cycle and supports the full spectrum of science from R&D to commercial realisation.
ImpactA report into the impact of the Babraham Institute, carried out by Alacrita LLP, has concluded that it makes major economic impacts through its world-class research. In addition to the Institute’s academic impact, it has made major scientific contributions to the commercial development of therapeutics in several key areas, for example the development of humanised monoclonal antibodies and PI3 Kinase inhibitors.